The Dimensional Global Core Plus Fixed Income ETF offers access to global bonds spanning government, corporate, and securitized markets.
A director at one of the top clinical-stage biotech companies sold 6,000 insider shares towards the end of January 2026 amid the company's stock having an underwhelming performance in 2025.